Chimeric Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:CHM Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
07 Dec 23	BuyAU$100,000	Phillip Hains	Individual	3,571,429	AU$0.028
12 Jul 23	BuyAU$5,000	Cynthia Elkins	Individual	108,695	AU$0.046
12 Jul 23	BuyAU$5,000	Leslie Chong	Individual	108,695	AU$0.046
12 Jul 23	BuyAU$80,001	Lesley Russell	Individual	1,739,130	AU$0.046
12 Jul 23	BuyAU$50,001	George Matcham	Individual	1,086,956	AU$0.046
12 Jul 23	BuyAU$5,000	Jennifer Chow	Individual	108,695	AU$0.046
12 Jul 23	BuyAU$600,006	Paul Hopper	Individual	13,043,478	AU$0.046

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 94.9%.

Top 4 shareholders own 14.69% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.2%	Paul Hopper	94,994,574	AU$2.6m	0%	no data
2.12%	Jennifer Chow	18,094,527	AU$488.6k	91.5%	no data
1.21%	Phillip Hains	10,326,028	AU$278.8k	0%	no data
0.2%	Lesley Russell	1,739,130	AU$47.0k	0%	no data